GSK plc ADRhedged
$71.34−0.12 (−0.17%)
- Expense ratio
- 0.17%
- Fund size
- $1M
- 1Y return
- +28.1%
- Yield · Last 12 months
- Data unavailable
- Volume · 30D
- 0M sh
- NAV per share
- $71.85
- 52W range
The ETF.net GSKH Grade
Score 40 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E. A structural cap ceilings this fund at 40, so B and A are out of reach.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 94Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 57Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.FScore 21Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.CScore 49Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.DScore 28Category rank
Our read on GSKH
CGSK, minus the currency noise. A single-stock ADR wrapper on the UK pharma giant with the pound hedge built in, so what you own is the stock's move rather than the exchange rate's.
The fund is an ADR-hedged ETF providing exposure to GSK plc, a global pharmaceutical and biotechnology company focused on vaccines.
Why people hold it
- The currency hedge is built into the wrapper, so holding a UK-listed drugmaker stays a pharma call instead of doubling as a pound call.precidian.com
- 0.19% a year, the same sticker carried across the ADRhedged lineup, for a hedge most individual investors cannot run cheaply themselves.
- One US-listed ticker covers the ADR and the hedge together, with distributions on a quarterly cadence.
Worth knowing
- Small and thinly traded, which usually means wider bid-ask spreads and more of the cost showing up in the trade itself.
- One company, one story: GSK's pipeline, patents and litigation headlines drive the entire position, with no diversification to soften them.
- A hedge works in both directions, stripping out pound gains along with pound losses, and the fund only launched in 2025, so its record is short.
GSKH Holdings
- Stocks
- —
- 100%
- GSK
Geography
- United Kingdom100.00%
Developed 100% · Emerging 0%
GSKH Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | GSKH |
|---|---|
| Year to date | +6.6% |
| 1 month | −1.2% |
| 3 months | −0.2% |
| 1 year | +28.1% |
| 3 years | — |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | GSKH |
|---|---|---|
| 2026 YTD | +6.6% | |
| 2025 | +37.1% |
GSKH in the news
ETF.net Research hasn’t filed on GSKH yet — coverage lands here as it’s written.
GSKH Dividends
- $0.93 per share
- Quarterly
Distribution data unavailable.
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 16, 2026 | Jun 23, 2026 | $0.93 |
| Mar 16, 2026 | Mar 23, 2026 | $0.36 |
| Dec 16, 2025 | Dec 24, 2025 | $0.79 |
GSKH Risk
- 21.4%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.86
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −19.7%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- −0.32
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
GSKH Cost
- The middle half of Currency-Hedged Funds funds
- Median 0.19%
No Currency-Hedged Funds fund charges less.